Supervised dosing with a long‐acting medication vs unsupervised consumption
Retention [ · patients with opioid dependence
Supervised dosing with a long‐acting medication showed no clear difference in retention ‐ retention at the end of treatment (number of participants) compared with unsupervised consumption (low certainty).
1 finding from 1 review
- Supervised dosing with a long‐acting opioid medication in the management of opioid dependence 2017 · Cochrane Headline outcomes onlyRR 0.99 [0.88, 1.12]4 studies · 716 participantsLow